ReviewTherapeutic advances in chronic disease2018

Secukinumab: a review of the anti-IL-17A biologic for the treatment of psoriasis.

Jillian Frieder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.